Inhibiting TGF-β signaling pathway for disease therapy: challenges and opportunities

Area of Science:

• Biochemistry and Molecular Biology
• Cell Biology
• Immunology

Background:

• Transforming growth factor-beta (TGF-β) is a key cytokine involved in numerous cellular processes.
• The TGF-β signaling pathway plays a vital role in embryonic development, tissue homeostasis, and adult tissue repair.
• Dysregulation of the TGF-β pathway is implicated in the pathogenesis of various diseases.

Purpose of the Study:

• To review recent research on the role of TGF-β in disease pathogenesis.
• To explore the therapeutic potential of targeting the TGF-β signaling pathway.
• To summarize current treatment strategies involving TGF-β.

Main Methods:

• Literature review of recent studies on TGF-β.
• Analysis of TGF-β's role in cancer, fibrosis, and autoimmune diseases.
• Evaluation of therapeutic interventions targeting TGF-β.

Main Results:

• TGF-β signaling is essential for normal physiological functions.
• Aberrant TGF-β signaling contributes to the development of cancer, fibrosis, vascular disorders, and autoimmune conditions.
• Selective TGF-β inhibitors show promise as therapeutic agents.

Conclusions:

• Targeting the TGF-β pathway presents a promising therapeutic strategy for multiple diseases.
• Further development of TGF-β inhibitors could lead to effective clinical treatments.
• Understanding TGF-β's role is critical for advancing disease treatment.